Altimmune Share Price
NASDAQ: ALT | Micro Cap | HealthcareAltimmune Stock Performance
Altimmune Share Price Today
As of 19 November 2026, Altimmune, Inc.'s share price is $1.41. The stock opened at $1.52, compared to its previous close of $1.53. During today's trading session, Altimmune, Inc.'s share price traded between $1.40 and $1.53, with an average price of $1.46. Over the past 52 weeks, the stock has recorded a high of $6.42 and a low of $1.40. In terms of performance, Altimmune, Inc.'s share price has declined by 53.77% over the last six months and is down 73.19% on a year-on-year basis.
Altimmune Share Price Chart
Altimmune Quarterly Profit & Loss
All figures in USD
Altimmune Annual Profit & Loss
All figures in USD
Altimmune Balance Sheet
All figures in USD Million
Altimmune Cash Flow
All figures in USD Million
Corporate Actions
About Altimmune
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
Altimmune Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $2.06 | $1.41 | -30.71% |
Oct 2026 | $2.85 | $2.04 | -28.97% |
Sep 2026 | $3.08 | $2.87 | -11.71% |
Aug 2026 | $2.90 | $3.25 | +13.86% |
Jul 2026 | $3.06 | $2.85 | -5.79% |
Jun 2026 | $3.03 | $3.02 | -0.82% |
May 2026 | $2.57 | $3.05 | +18.22% |
Apr 2026 | $3.15 | $2.58 | -15.96% |
Mar 2026 | $4.22 | $3.07 | -28.77% |
Feb 2026 | $5.55 | $4.31 | -23.17% |
Jan 2026 | $3.62 | $5.61 | +55.62% |
Dec 2025 | $5.08 | $3.60 | -31.46% |